Nu Skin Enterprises (NUS)
(Delayed Data from NYSE)
$8.35 USD
0.00 (0.00%)
Updated Sep 5, 2024 04:00 PM ET
After-Market: $8.44 +0.09 (1.08%) 6:40 PM ET
5-Strong Sell of 5 5
A Value B Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$8.35 USD
0.00 (0.00%)
Updated Sep 5, 2024 04:00 PM ET
After-Market: $8.44 +0.09 (1.08%) 6:40 PM ET
5-Strong Sell of 5 5
A Value B Growth A Momentum A VGM
Zacks News
NUS or EL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
NUS vs. EL: Which Stock Is the Better Value Option?
Are Investors Undervaluing Nu Skin Enterprises (NUS) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Procter & Gamble (PG) Q2 Earnings & Sales Beat, FY21 View Up
by Zacks Equity Research
Procter & Gamble's (PG) Q2 results gain from solid performance across all segments as well as a rise in organic shipment volumes, improved pricing and mix. Encouragingly, it lifts fiscal 2021 view.
3 Factors That Makes Helen of Troy (HELE) a Promising Pick
by Zacks Equity Research
Helen of Troy (HELE) is focused on making solid investments in its Leadership Brands. Also, strength in the company's online business is yielding.
Inter Parfums' (IPAR) Subsidiary to Buy Office Building Complex
by Zacks Equity Research
Inter Parfums' (IPAR) subsidiary Interparfums SA to buy property in Paris, which will be used as its headquarters. Management expects to close the transaction during spring of 2021.
Why Nu Skin (NUS) Could Beat Earnings Estimates Again
by Zacks Equity Research
Nu Skin (NUS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Has Nu Skin Enterprises (NUS) Outpaced Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Is (NUS) Outperforming Other Consumer Staples Stocks This Year?
Nu Skin (NUS) Looks Buoyant, Stock Up More Than 35% in a Year
by Zacks Equity Research
Nu Skin (NUS) has been benefiting from focus on innovation as well as commitment to strengthening sales leaders.
Estee Lauder (EL) Looks Solid on Online Business & Savings
by Zacks Equity Research
Estee Lauder (EL) is implementing new technology and digital experiences to boost online sales. Also, strength in the Skin Care category is driving growth.
Helen of Troy's (HELE) Q3 Earnings Beat Estimates, Sales Up Y/Y
by Zacks Equity Research
Helen of Troy's (HELE) third-quarter fiscal 2021 results reflect strength across the Beauty and the Health & Home segments along with gains in online business.
Is Nu Skin Enterprises (NUS) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
NUS vs. EL: Which Stock Is the Better Value Option?
by Zacks Equity Research
NUS vs. EL: Which Stock Is the Better Value Option?
Coty (COTY) Aids Beauty Categories With Kim Kardashian West Deal
by Zacks Equity Research
Coty (COTY) buys a 20% stake in Kim Kardashian West's business. The company's industry knowledge and Kim Kardashian West's robust following are likely to benefit both.
Nu Skin (NUS) Down 5.3% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Splunk (SPLK) Incurs Loss in Q3 Earnings, Revenues Down Y/Y
by Zacks Equity Research
Splunk's (SPLK) third-quarter fiscal 2021 results reflect growth in cloud revenues and customer base expansion despite decline in license revenues.
Estee Lauder (EL) Gains on Solid Online Business & Savings
by Zacks Equity Research
Estee Lauder (EL) is benefiting from its robust e-commerce business, especially amid the COVID-19 outbreak. Also, its solid presence in emerging markets is impressive.
Helen of Troy Limited (HELE) Gains on Robust Online Business
by Zacks Equity Research
Helen of Troy (HELE) is benefiting from its robust e-commerce business, especially amid COVID-19. Also, strength in its Leadership Brands is yielding.
Zacks.com featured highlights include: TeleTech, Thermo Fisher, Best Buy, ParkerHannifin and Nu Skin
by Zacks Equity Research
Zacks.com featured highlights include: TeleTech, Thermo Fisher, Best Buy, ParkerHannifin and Nu Skin
Nu Skin (NUS) Looks Radiant on Innovation & Digital Strength
by Zacks Equity Research
Nu Skin (NUS) has been gaining on initiatives to strengthen sales leader and expand customer base through product launches. Also, the company's focus on digital operations bodes well.
Is Colgate (CL) Benefiting From Healthy Consumer Good Demand?
by Zacks Equity Research
Colgate (CL) benefits from the increase in demand for personal and home care products due to the pandemic-led increase in hygiene habits.
3 Reasons Why Growth Investors Shouldn't Overlook Nu Skin (NUS)
by Zacks Equity Research
Nu Skin (NUS) possesses solid growth attributes, which could help it handily outperform the market.
5 Top Dividend Growth Stocks to Buy on the Cheap
by Sweta Killa
Honing in on stocks with a history of dividend growth leads to a healthy portfolio, with greater scope of capital appreciation as opposed to simple dividend-paying stocks or those with high yields.
Should Value Investors Buy Nu Skin Enterprises (NUS) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
NUS or EL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
NUS vs. EL: Which Stock Is the Better Value Option?
Is Nu Skin Enterprises (NUS) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Is (NUS) Outperforming Other Consumer Staples Stocks This Year?